Q32 Bio
QTTB
QTTB
86 hedge funds and large institutions have $756M invested in Q32 Bio in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% more funds holding
Funds holding: 80 → 86 (+6)
0.64% more ownership
Funds ownership: 3.97% → 4.61% (+0.64%)
97% less call options, than puts
Call options by funds: $28K | Put options by funds: $924K
Holders
86
Holding in Top 10
4
Calls
$28K
Puts
$924K
Top Buyers
| 1 | +$30.2M | |
| 2 | +$7.17M | |
| 3 | +$1.4M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.13M |
| 5 |
Millennium Management
New York
|
+$905K |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$11.3M | |
| 3 | -$8.19M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.44M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$4.07M |